{"id":127432,"date":"2022-05-23T07:03:20","date_gmt":"2022-05-23T07:03:20","guid":{"rendered":"https:\/\/fin2me.com\/?p=127432"},"modified":"2022-05-23T07:03:20","modified_gmt":"2022-05-23T07:03:20","slug":"creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens","status":"publish","type":"post","link":"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/","title":{"rendered":"Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens"},"content":{"rendered":"<p> Creo Medical Group plc (CREO.L), a medical device company focused on surgical endoscopy, Monday announced that it has signed a long-term, multi-year collaboration agreement with Intuitive Surgical Inc. (ISRG) to optimise certain Creo products to be compatible with Intuitive&#8217;s robotic <span>technology<\/span>.<\/p>\n<p>Intuitive is focused on minimally invasive care and the pioneer of robotic-assisted surgery, .  <\/p>\n<p>Under the deal, the companies will also undertake joint clinical studies. The agreement includes a number of milestone payments to be made to Creo. Future royalty structures have also been agreed for any products which may be sold in the future.  <\/p>\n<p>Creo noted that it is developing and commercialising a suite of electrosurgical medical devices, each enabled by the CROMA Advanced Energy platform and powered by Kamaptive, full-spectrum adaptive technology to help support surgical capability and patient outcomes. <\/p>\n<p>Craig Gulliford, Chief Executive Officer of Creo, said, &#8220;The combination of Intuitive&#8217;s robotic platforms and our Kamaptive Technology strives to provide patients with additional treatment options using state-of-the-art technology.&#8221;<\/p>\n<p>Separately, Creo reported fiscal 2021 loss before income tax of 30.34 million pounds, wider than last year&#8217;s loss of 23.46 million pounds. Loss per share was 15 pence, compared to loss of 13 pence a year ago.<\/p>\n<p>Operating loss widened to 29.91 million pounds, and underlying operating loss widened to 19.04 million pounds from prior year&#8217;s 18.01 million pounds.<\/p>\n<p>Total sales in the period climbed to 25.2 million pounds from prior year&#8217;s 9.4 million pounds. <\/p>\n<p>Source: <a href=\"https:\/\/www.rttnews.com\/3285888\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens.aspx?type=ern\" target=\"_blank\" rel=\"noopener\">Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Creo Medical Group plc (CREO.L), a medical device company focused on surgical endoscopy, Monday announced that it has signed a long-term, multi-year collaboration agreement with [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":127431,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens - Fin2me\" \/>\n<meta property=\"og:description\" content=\"Creo Medical Group plc (CREO.L), a medical device company focused on surgical endoscopy, Monday announced that it has signed a long-term, multi-year collaboration agreement with [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-23T07:03:20+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2022\/05\/Creo-Medical-Signs-Long-term-Collaboration-Deal-With-Intuitive-FY21-Loss-Widens-.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/\",\"url\":\"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/\",\"name\":\"Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2022-05-23T07:03:20+00:00\",\"dateModified\":\"2022-05-23T07:03:20+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Economy\",\"item\":\"https:\/\/fin2me.com\/category\/economy\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/","og_locale":"en_US","og_type":"article","og_title":"Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens - Fin2me","og_description":"Creo Medical Group plc (CREO.L), a medical device company focused on surgical endoscopy, Monday announced that it has signed a long-term, multi-year collaboration agreement with [...]","og_url":"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/","og_site_name":"Fin2me","article_published_time":"2022-05-23T07:03:20+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2022\/05\/Creo-Medical-Signs-Long-term-Collaboration-Deal-With-Intuitive-FY21-Loss-Widens-.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/","url":"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/","name":"Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2022-05-23T07:03:20+00:00","dateModified":"2022-05-23T07:03:20+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/economy\/creo-medical-signs-long-term-collaboration-deal-with-intuitive-fy21-loss-widens\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Economy","item":"https:\/\/fin2me.com\/category\/economy\/"},{"@type":"ListItem","position":3,"name":"Creo Medical Signs Long-term Collaboration Deal With Intuitive; FY21 Loss Widens"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/127432"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=127432"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/127432\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/127431"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=127432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=127432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=127432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}